New Medicaid Bulletins Available as of Feb. 9

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:

Rituximab-arrx Injection, for Intravenous Use (Riabni™) HCPCS Code J3590: Billing Guidelines

Effective with date of service Jan. 5, 2021, the Medicaid and NC Health Choice programs cover rituximab-arrx injection, for intravenous use (Riabni™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3590 - Unclassified biologics. More information

Lumasiran Injection, for Subcutaneous Use (Oxlumo™) HCPCS Code J3490: Billing Guidelines

Effective with date of service Dec. 22, 2020, the Medicaid and NC Health Choice programs cover lumasiran injection, for subcutaneous use (Oxlumo™) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs. Details

Addition of Licensed Professionals Eligible to Bill Screening, Brief Intervention and Referral to Treatment (SBIRT) CPT Codes

This bulletin informs LME-MCOs and providers about the amendments made to provider types eligible to bill the Screening, Brief Intervention and Referral to Treatment (SBIRT) CPT codes effective March 1, 2021. Read more

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.